million or 788.21 % compared to the year 2017, varied to the decreasing of revenue from sales of land and houses , details as presented in operating revenue table. Gross profit margin for the year as at
, details as presented in operating revenue table. Gross profit margin for the nine month as at September 2018 and as at September 2017 as 31.98%, 10.14 % increase 21.84% 4. Expenses 4.1 Distribution cost In
sales of land and houses, details as presented in operating revenue table. Gross profit margin for the nine month as at September 2019 and as at September 2018 as 25.02%, 31.98% decrease 6.96%. 4
not restating the prior year's financial statements presented for comparison. The company has current liabilities of THB 99.75 million, a decrease from as of December 31, 2019, which is THB 127.97
of 2020. The Company (iiG) and ICE/iiXP (the subsidiaries), recorded the total Assets of 443.14 Mb.and 480.68 Mb respectively. The current assets presented in the audited financial statement consist of
with the same period of last year. The income statement in brief is presented as following: DOD BIOTECH PUBLIC COMPANY LIMITED เลขที ่111 หมู่ที ่2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000
revenue from goods sold and revenue from rental and service increased notably in 2019 which lead to presenting cost of those revenue separately in other expenses (previous year was presented net with other
incident of electrical short circuit since Q3/2018. However, in Q1/2019 the company received insurance claim presented as other income. 4. Trading business had revenue in Q2/2019 at the same level of gross